Survey Finds 1.7-Fold Increase in Patients Prescribed DPP-4 Inhibitors Over 2-Year Period: MDV

The results of a survey on the prescription of diabetes treatments announced on December 5 by Medical Data Vision Co. Ltd. (MDV), a company that surveys and analyzes medical data, revealed that the number of patients prescribed dipeptidyl peptidase-4 (DPP-4)...read more